• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Therapy of colon carcinoma: an oncology perspective. Interview with Piotr M. Czaykowski by Paul C. Adams.

作者信息

Czaykowski Piotr M

机构信息

Department of Internal Medicine, University of Manitoba, Winnipeg.

出版信息

Can J Gastroenterol. 2007 Aug;21(8):483-6. doi: 10.1155/2007/259752.

DOI:10.1155/2007/259752
PMID:17874485
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2657971/
Abstract
摘要

相似文献

1
Therapy of colon carcinoma: an oncology perspective. Interview with Piotr M. Czaykowski by Paul C. Adams.结肠癌治疗：肿瘤学视角。保罗·C·亚当斯对彼得·M·恰伊科夫斯基的访谈。
Can J Gastroenterol. 2007 Aug;21(8):483-6. doi: 10.1155/2007/259752.
2
Successful and well-tolerated second line therapy with cetuximab, irinotecan, and raltitrexed in progressive liver disease due to metastatic colon cancer.西妥昔单抗、伊立替康和雷替曲塞用于转移性结肠癌所致进行性肝病的二线治疗成功且耐受性良好。
J Gastrointest Cancer. 2008;39(1-4):26-8. doi: 10.1007/s12029-009-9060-4. Epub 2009 May 6.
3
Chemotherapy with bevacizumab, irinotecan, 5-fluorouracil and leucovorin (IFL) associated with a large, embolizing thrombus in the thoracic aorta.使用贝伐单抗、伊立替康、5-氟尿嘧啶和亚叶酸钙（IFL）进行化疗，伴有胸主动脉内一个巨大的、有栓子形成的血栓。
Ann Oncol. 2006 Dec;17(12):1851-2. doi: 10.1093/annonc/mdl140. Epub 2006 Jun 15.
4
Adaptation of international guidelines for metastatic colorectal cancer: an asian consensus.《转移性结直肠癌国际指南的改编：亚洲共识》
Clin Colorectal Cancer. 2014 Sep;13(3):145-55. doi: 10.1016/j.clcc.2014.06.004. Epub 2014 Jun 26.
5
[Colorectal cancer: irinotecan in combination with newer drugs].[结直肠癌：伊立替康与新型药物联合应用]
Tumori. 2001 Nov-Dec;87(6):A31-3.
6
[Evaluation of bevacizumab combined with irinotecan-based regimen as the first-line treatment for patients with metastatic colorectal cancer].贝伐单抗联合以伊立替康为基础的方案作为转移性结直肠癌患者一线治疗的评估
Zhonghua Zhong Liu Za Zhi. 2010 Oct;32(10):786-90.
7
Carcinoembryonic antigen antibody inhibits lung metastasis and augments chemotherapy in a human colonic carcinoma xenograft.癌胚抗原抗体抑制人结肠癌异种移植瘤的肺转移并增强化疗效果。
Cancer Immunol Immunother. 2005 Apr;54(4):315-27. doi: 10.1007/s00262-004-0597-6. Epub 2004 Dec 11.
8
[A case of advanced right colonic cancer successfully treated by surgery and post operative chemotherapy].[一例经手术及术后化疗成功治疗的晚期右结肠癌病例]
Gan To Kagaku Ryoho. 2009 Nov;36(12):2210-2.
9
Selecting regimens in advanced colon cancer.晚期结肠癌治疗方案的选择
J Natl Compr Canc Netw. 2004 Sep;2 Suppl 3:S-19-24.
10
Intensified neoadjuvant radiochemotherapy for locally advanced rectal cancer: a review.局部晚期直肠癌的强化新辅助放化疗：综述
Int J Colorectal Dis. 2007 May;22(5):457-65. doi: 10.1007/s00384-006-0204-8. Epub 2006 Oct 28.

本文引用的文献

1
Cost of cancer care: issues and implications.癌症护理费用：问题与影响
J Clin Oncol. 2007 Jan 10;25(2):180-6. doi: 10.1200/JCO.2006.09.6081.
2
How should we pay the piper when he's calling the tune? On the long-term affordability of cancer care in the United States.当吹笛者定好曲调时，我们该如何付费呢？关于美国癌症治疗的长期可负担性。
J Clin Oncol. 2007 Jan 10;25(2):175-9. doi: 10.1200/JCO.2006.08.9805.
3
Downstaging or downsizing: time for a new staging system in advanced colorectal cancer?降期或缩小肿瘤大小：是时候为晚期结直肠癌建立新的分期系统了吗？
J Clin Oncol. 2006 Jun 20;24(18):2702-6. doi: 10.1200/JCO.2006.05.8404.
4
Colon cancer survival is associated with decreasing ratio of metastatic to examined lymph nodes.结肠癌的生存率与转移淋巴结与检查淋巴结的比例下降有关。
J Clin Oncol. 2005 Dec 1;23(34):8706-12. doi: 10.1200/JCO.2005.02.8852.
5
Factors predicting survival in stage IV colorectal carcinoma patients after palliative treatment: a multivariate analysis.姑息治疗后IV期结直肠癌患者生存的预测因素：一项多变量分析
J Surg Oncol. 2005 Mar 15;89(4):211-7. doi: 10.1002/jso.20196.
6
Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer.西妥昔单抗单药治疗及西妥昔单抗联合伊立替康治疗伊立替康难治性转移性结直肠癌。
N Engl J Med. 2004 Jul 22;351(4):337-45. doi: 10.1056/NEJMoa033025.
7
Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer.奥沙利铂、氟尿嘧啶和亚叶酸作为结肠癌的辅助治疗。
N Engl J Med. 2004 Jun 3;350(23):2343-51. doi: 10.1056/NEJMoa032709.
8
Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer.贝伐单抗联合伊立替康、氟尿嘧啶和亚叶酸钙治疗转移性结直肠癌。
N Engl J Med. 2004 Jun 3;350(23):2335-42. doi: 10.1056/NEJMoa032691.
9
FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: a randomized GERCOR study.晚期结直肠癌中FOLFIRI序贯FOLFOX6或相反顺序：一项GERCOR随机研究
J Clin Oncol. 2004 Jan 15;22(2):229-37. doi: 10.1200/JCO.2004.05.113. Epub 2003 Dec 2.
10
Colon cancer survival is associated with increasing number of lymph nodes analyzed: a secondary survey of intergroup trial INT-0089.结肠癌生存率与所分析淋巴结数量的增加相关：对组间试验INT - 0089的二次调查
J Clin Oncol. 2003 Aug 1;21(15):2912-9. doi: 10.1200/JCO.2003.05.062.